Screening of chemical libraries in pursuit of kallikrein-5 specific inhibitors for the treatment of inflammatory dermatoses (original) (raw)
Identification by in silico and in vitro screenings of small organic molecules acting as reversible inhibitors of kallikreins
Chahrazade Amri
European Journal of Medicinal Chemistry, 2013
View PDFchevron_right
Toward the First Class of Suicide Inhibitors of Kallikreins Involved in Skin Diseases
Xiao Tan, Feryel Soualmia
Journal of Medicinal Chemistry, 2015
View PDFchevron_right
Natural and engineered kallikrein inhibitors: an emerging pharmacopoeia
Joakim Swedberg
Biological Chemistry, 2000
View PDFchevron_right
Natural and synthetic inhibitors of kallikrein-related peptidases (KLKs)
Peter Goettig, Viktor Magdolen
Biochimie, 2010
View PDFchevron_right
Pyrido-imidazodiazepinones as a new class of reversible inhibitors of human kallikrein 7
Feryel Soualmia
European Journal of Medicinal Chemistry, 2015
View PDFchevron_right
Isomannide derivatives as new class of inhibitors for human kallikrein 7
Luiz Juliano
Bioorganic & Medicinal Chemistry Letters, 2012
View PDFchevron_right
Biological evaluation and docking studies of natural isocoumarins as inhibitors for human kallikrein 5 and 7
LUCAS SOUZA
Bioorganic & Medicinal Chemistry Letters, 2011
View PDFchevron_right
Isomannide-Based Peptidomimetics as Inhibitors for Human Tissue Kallikreins 5 and 7
Thalita Barros
ACS Medicinal Chemistry Letters, 2014
View PDFchevron_right
Exploring the active site binding specificity of kallikrein-related peptidase 5 (KLK5) guides the design of new peptide substrates and inhibitors
Maria Brattsand
Biological chemistry, 2016
View PDFchevron_right
Identification of human IKK-2 inhibitors of natural origin (Part II): In Silico prediction of IKK-2 inhibitors in natural extracts with known anti-inflammatory activity
Aurélien Grosdidier
European Journal of Medicinal Chemistry, 2011
View PDFchevron_right
Herbal Arsenal against Skin Ailments: A Review Supported by In Silico Molecular Docking Studies
deepika bhatia
Molecules
View PDFchevron_right
Biochemical characterization of a novel high-affinity and specific plasma kallikrein inhibitor
Parth Akbari
British Journal of Pharmacology, 2011
View PDFchevron_right
Persistent kallikrein5 activation induces atopic dermatitis-like skin architecture independent of PAR2 activity
Peter Friedmann
The Journal of allergy and clinical immunology, 2017
View PDFchevron_right
Synthesis of potent and selective inhibitors of human plasma kallikrein
Garry Garrett
Bioorganic & Medicinal Chemistry Letters, 1999
View PDFchevron_right
Characterization of SPINK9, a KLK5-specific inhibitor expressed in palmo-plantar epidermis
Maria Brattsand
Biological Chemistry, 2000
View PDFchevron_right
Synthesis and Structure–Activity Relationships of N-(4-Benzamidino)-Oxazolidinones–Potent and Selective Inhibitors of Kallikrein-Related Peptidase 6
Natalia Ignatenko
View PDFchevron_right
Discovery of a new isomannide-based peptidomimetic synthetized by Ugi multicomponent reaction as human tissue kallikrein 1 inhibitor
Ana Carolina Rennó Sodero
Bioorganic & Medicinal Chemistry Letters, 2017
View PDFchevron_right
A novel theranostic activity-based probe targeting kallikrein 7 for the diagnosis and treatment of skin diseases
Evangelos Bisyris
Chem. Commun., 2021, 57, 6507–6510 , 2021
View PDFchevron_right
Identification of Lympho-Epithelial Kazal-Type Inhibitor 2 in Human Skin as a Kallikrein-Related Peptidase 5-Specific Protease Inhibitor
Ulf Meyer-hoffert
PLoS ONE, 2009
View PDFchevron_right
Design of kallidin-releasing tissue kallikrein inhibitors based on the specificities of the enzyme's binding subsites
Luiz Juliano, Maria Helena Sedenho Cezari
1997
View PDFchevron_right
Structural Studies on the Inhibitory Binding Mode of Aromatic Coumarinic Esters to Human Kallikrein-Related Peptidase 7
Michele Reboud-ravaux
View PDFchevron_right
Synthesis, biological evaluation, and docking studies of PAR2-AP-derived pseudopeptides as inhibitors of kallikrein 5 and 6
Luiz Juliano
Biological Chemistry, 2015
View PDFchevron_right
The non-peptide kinin receptor antagonists FR 173657 and SSR 240612: Preclinical evidence for the treatment of skin inflammation
Daniela Cabrini
Regulatory Peptides, 2009
View PDFchevron_right
Inhibition of human kallikreins 5 and 7 by the serine protease inhibitor lympho-epithelial Kazal-type inhibitor (LEKTI)
Yaan Kang
Biological Chemistry, 2005
View PDFchevron_right
The natural flavone fukugetin as a mixed-type inhibitor for human tissue kallikreins
Teodorico C. Ramalho
Bioorganic & Medicinal Chemistry Letters, 2016
View PDFchevron_right
Hit identification of IKKβ natural product inhibitor
dik ma
BMC pharmacology & toxicology, 2013
View PDFchevron_right
Virtual Screening and X-ray Crystallography for Human Kallikrein 6 Inhibitors with an Amidinothiophene P1 Group
Rachel Wang
ACS Medicinal Chemistry Letters, 2012
View PDFchevron_right
Novel Inhibitory Activity for Serine Protease Inhibitor Kazal Type-3 (Spink3) on Human Recombinant Kallikreins
Diego Assis
Protein & Peptide Letters, 2013
View PDFchevron_right